VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

Bullboard Posts

Comment by snuff69on Jan 21, 2018 2:10pm

301 Views

Post# 27403894

RE:VPT Sales

Yes I talked to GA on Wednesday after the halt , he assured me sales will most likely be the next nr and we will be all hearing something in the very near future . By the tone of his voice I say we hear something this week but we will all see . A halt with sales and the Chinese approval would be a great way to start of the week tommorow
Good luck all

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading